DALLAS, Oct. 16, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the addition of seven clinical sites that are currently enrolling to support the development of its diabetic foot ulcer (DFU) application for the DeepView® Wound Imaging System. The proprietary technology combines multi-spectral imaging and AI technology to provide clinicians with an immediate healing assessment of DFU’s for more accurate and timely diagnosis and therapeutic intervention.
BlogofInnovation.com
NASHVILLE, Tenn., Dec. 11, 2024 — Representatives from 20 local Metro Nashville Public Schools (MNPS) joined the American Heart Association…
MESA, Ariz., Dec. 11, 2024 (SEND2PRESS NEWSWIRE) — Edupoint® Educational Systems, creator of the industry-leading Synergy® Education Platform for K-12…
FREMONT, Calif. - (NewMediaWire) - December 11, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions…
NEW YORK, N.Y., Dec. 10, 2024 (SEND2PRESS NEWSWIRE) — HitPaw, a leading software company, is excited to announce the new…
DALLAS, Texas, Dec. 10, 2024 (SEND2PRESS NEWSWIRE) — ProNotary, a pioneering force in the remote online notarization (RON) industry, today…
DALLAS, Dec. 10, 2024 — Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure,…
